Search

everythinglearnresearchcommunity

for

Search:↓

Rapid virilization should be checked for possible ovarian or adrenal cancer.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

The AMHR2-482A>G gene change is linked to higher PCOS risk.

The laser treatment effectively reduced hair growth in women with hirsutism, with temporary side effects.

The treatment successfully lowered testosterone levels and reduced symptoms.

Erythematous papulopustular eruptions in cancer patients using EGFR inhibitors show specific skin changes that vary with severity and treatment type.

LncRNAs may help improve brain cancer treatment and diagnosis.

Erlotinib can cause unusual hair growth, like long eyelashes and facial hair.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

Excessive male hormones in women cause symptoms like unwanted hair growth, and treatment requires careful medical evaluation.

A 63-year-old woman's male-like symptoms were caused by a rare testosterone-producing ovarian tumor, treated by removing her ovaries and fallopian tubes.

Removing an adrenal tumor can significantly reduce high androgen levels in postmenopausal women.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

A woman's masculine symptoms were caused by a rare tumor in her left ovary, which was found using a special blood test.

An 80-year-old woman's severe hair loss was caused by a hormone-secreting ovarian tumor.

Mutant cells in hair follicles are influenced by their location and interactions with surrounding cells.

A woman's excessive hair growth was linked to a rare case of high testosterone caused by a prolactin-producing pituitary tumor.

Taking thyroid medication reduced the patient's pituitary gland swelling and improved her symptoms.

ACTH-dependent Cushing's syndrome linked to metastatic cervical cancer is rare and has high risks.

The E2 protein affects gene activity in hair follicles of mice.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Both vaginal testosterone cream and Estring effectively manage vaginal dryness in women with early-stage breast cancer on aromatase inhibitors.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

Markers CRABP1, Nestin, and Ephrin B2 are present in skin cancer environments and may influence their development.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.